Literature DB >> 4098907

Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity.

P W Howie, A C Mallinson, C R Prentice, C H Horne, G P McNicol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4098907     DOI: 10.1016/s0140-6736(70)92358-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

1.  Pancreatitis, multiple infarcts and oral contraception.

Authors:  M E Foster; D E Powell
Journal:  Postgrad Med J       Date:  1975-09       Impact factor: 2.401

2.  Enhanced antiplasmin activity in acute renal failure.

Authors:  A Kanfer; A Vandewalle; M Beaufils; F Delarue; J D Sraer
Journal:  Br Med J       Date:  1975-10-25

3.  Elective surgery and the pill.

Authors: 
Journal:  Br Med J       Date:  1976-09-04

Review 4.  Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

5.  Blood clotting and the pill.

Authors: 
Journal:  Br Med J       Date:  1972-11-18

6.  Cryptogenic cerebral embolism in women taking oral contraceptives.

Authors:  K Enzell; G Lindemalm
Journal:  Br Med J       Date:  1973-12-01

7.  Changes in thrombin-stimulated platelet malondialdehyde production during the menstrual cycle.

Authors:  H Tindall; M Zuzel; R C Paton; G P McNicol
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

8.  Preoperative prediction of postoperative deep vein thrombosis.

Authors:  J K Clayton; J A Anderson; G P McNicol
Journal:  Br Med J       Date:  1976-10-16

9.  Effect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysis.

Authors:  P W Howie; A A Calder; C D Forbes; C R Prentice
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411

10.  Mesterolone: thrombosis during treatment, and a study of its prothrombotic effects.

Authors:  G D Lowe; J E Thomson; M M Reavey; C D Forbes; C R Prentice
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.